FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the chemical and pharmaceutical industry and is an antitussive or expectorant composition comprising a dry aqueous extract of Coptis rhizome and a cation-exchange resin having a sulphonic acid group, where the bitter taste of the dry aqueous extract of Coptis rhizome is masked by a cation-exchange resin having a sulphonic acid group; and the ratio of the content of the dry aqueous extract of Coptis rhizome to the content of the cation-exchange resin having a sulphonic acid group in the composition ranges from 1:1 to 1:10 (w/w).
EFFECT: invention enables to mask the bitter taste of the dry aqueous extract of Coptis rhizome using a cation-exchange resin having a sulphonic acid group.
12 cl, 4 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED LIQUID PHARMACEUTICAL COMPOSITION CONTAINING A CRUDE DRIED POWDER, A STABILIZING DRUG | 2017 |
|
RU2703734C1 |
EXTRACT COPTIDIS RHIZOMA AND ITS USE IN TREATING RESPIRATORY DISEASE | 2009 |
|
RU2461388C1 |
SOLID PREPARATIONS CONTAINING PELARGONIUM SIDOIDES EXTRACTS AND SILICIC ACID COMPOUNDS AND PRODUCTION METHODS | 2014 |
|
RU2612085C1 |
GATIFLOXACIN FORMULATIONS FOR USING IN PEDIATRICS | 2002 |
|
RU2288218C2 |
ZOLPIDEM COMPOSITION AND A METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2690159C1 |
CEFUROXIME AXETYL-CONTAINING PHARMACEUTICAL COMPOSITION WITH MASKED BITTER TASTE | 2002 |
|
RU2241460C2 |
PAROXETINE CHOLATE OR SALTS OF CHOLIC ACID DERIVATIVES AND COMPOSITION CONTAINING PAROXETINE AND CHOLIC ACID OR CHOLIC ACID DERIVATIVES | 2004 |
|
RU2337919C2 |
REBAUDIOSIDE D OF HIGH PURITY AND USE THEREOF | 2010 |
|
RU2596190C9 |
FOOD INGREDIENTS OF STEVIA REBAUDIANA | 2017 |
|
RU2772126C2 |
USAGE OF RUBOZOZID FOR ATTENUATION OR SUPPRESSION OF CERTAIN UNPLEASANT TASTE SENSATIONS | 2011 |
|
RU2567175C2 |
Authors
Dates
2018-09-21—Published
2014-04-29—Filed